Abstract
Purpose
To appraise the ability of the computed tomography (CT) radiomics signature for prediction of early recurrence (ER) in patients with hepatocellular carcinoma (HCC).
Methods
A set of 325 HCC patients were enrolled in this retrospective study and the whole dataset was divided into 2 cohorts, including “training set” (225 patients) and “test set” (100 patients). All patients who underwent partial hepatectomy were followed up at least within 1 year. 656 Radiomics features were extracted from arterial-phase and portal venous-phase CT images. Lasso regression model was used for data dimension reduction, feature selection, and radiomics signature building. Univariate analysis was used to identify clinical and radiomics significant features. Models (radiomics signature, clinical model, and combined model) were evaluated by area under the curve (AUC) of receiver operating characteristic curve. The models’ performances for prediction of ER were assessed.
Results
The radiomics signature was built by 14 selected radiomics features and was significantly associated with ER (P < 0.001); the AUCs of the “train set” and the “test set” were 0.818 (95% CI 0.760–0.865) and 0.719 (95% CI 0.621–0.805), respectively. The tumor size, tumor capsule, and γ-glutamyl transferase (GGT) were significantly associated with ER in the clinical model (P < 0.05). The combined model showed incremental prognostic value, with the AUCs of “training dataset” and “test dataset” were 0.846 (95% CI 0.792–0.890) and 0.737 (95% CI 0.640–0.820), respectively. The radiomics signature, tumor size, and the level of GGT were independent predictors of ER (P < 0.05).
Conclusions
The CT radiomics signature can be conveniently used to predict the ER in patient with HCC. The combined model performed better for prediction of ER than radiomics signature or clinical model.
Similar content being viewed by others
References
Shah, S.A., et al., Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg, 2006. 202(2): p. 275–83.
Peery, A.F., et al., Burden of Gastrointestinal Disease in the United States: 2012 Update. Gastroenterology, 2012. 143(5): p. 1179–1187.e3.
Pang, Q., et al., Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J. Gastroenterol., 2015. 21(18): p. 5607–21.
Lu, L., A. Cheng, and R. Poon, Recent advances in the prevention of hepatocellular carcinoma recurrence. Semin. Liver Dis., 2014. 34(4): p. 427–34.
LC, L., C. AL, and P. RT, Recent advances in the prevention of hepatocellular carcinoma recurrence. Seminars in liver disease, 2014. 34(4): p. 427–34.
Zhou, Y., et al., CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol (NY), 2017. 42(6): p. 1695–1704.
Regimbeau, J., et al., Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol, 2004. 85(1): p. 36–41.
Ikeda, Y., et al., Early recurrence after surgery of hepatocellular carcinoma. Hepatogastroenterology, 1995. 42(5): p. 469–72.
Nagao, T., et al., Postoperative recurrence of hepatocellular carcinoma. Ann. Surg., 1990. 211(1): p. 28–33.
Shirabe, K., et al., Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology, 1991. 14(5): p. 802–5.
Poon, R., et al., Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 2000. 89(3): p. 500–7.
Tarao, K., et al., Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology, 2000. 43(1): p. 20–6.
Gillies, R.J., P.E. Kinahan, and H. Hricak, Radiomics: Images Are More than Pictures, They Are Data. Radiology, 2016. 278(2): p. 563–77.
Cunliffe, A., et al., Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development. Int. J. Radiat. Oncol. Biol. Phys., 2015. 91(5): p. 1048–56.
Huang, Y.Q., et al., Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. J Clin Oncol, 2016. 34(18): p. 2157–64.
Chou, C., et al., Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging. Br J Radiol, 2012. 85(1014): p. 778–83.
Sauerbrei, W., P. Royston, and H. Binder, Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med, 2007. 26(30): p. 5512–28.
Yip, S.S. and H.J. Aerts, Applications and limitations of radiomics. Phys Med Biol, 2016. 61(13): p. R150–66.
Buckler, A., et al., A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology, 2011. 258(3): p. 906–14.
Ma, Z., et al., CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma. Eur J Radiol, 2017. 91: p. 142–147.
21. Nagasue, N., et al., Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology, 1993. 105(2): p. 488–94.
Kosuge, T., et al., Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology, 1993. 40(4): p. 328–32.
Belghiti, J., et al., Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg., 1991. 214(2): p. 114–7.
Ko, S., et al., Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann. Surg., 1996. 224(5): p. 591–5.
Jwo, S., et al., Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology, 1992. 16(6): p. 1367–71.
Drozdz, R., et al., gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic. Biol. Med., 1998. 25(7): p. 786–92.
Fentiman, I., Gamma-glutamyl transferase: risk and prognosis of cancer. Br. J. Cancer, 2012. 106(9): p. 1467–8.
Acknowledgements
We would like to give many thanks to our technicians, nurses, as well as other staff of the department.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Ethical approval was obtained from the Ethics Committee of Zhengzhou University People’s Hospital.
Informed consent
Informed consent was waived.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ning, P., Gao, F., Hai, J. et al. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol 45, 64–72 (2020). https://doi.org/10.1007/s00261-019-02198-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-019-02198-7